Fulgent Genetics
FLGT
NASDAQ
IPO2016
about FLGT
Fulgent Genetics provides advanced genetic testing solutions for the diagnosis of rare diseases, cancer, and other genetic disorders, enabling accurate patient care through molecular insights.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $23.67 | $24.91 | $23.56 | $728.30M | 632.58K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.00 | n/a | 9.07 | -18.26% | -8.12% | 0% |